Fairmount Funds Management LLC Tyra Biosciences, Inc. Transaction History

Fairmount Funds Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$13.15 - $16.08 $311,247 - $380,597	-23,669 Reduced 1.67%	1,393,329 $19.2 Million
Q2 2022 Aug 15, 2022	BUY	$5.26 - $11.19 $694,362 - $1.48 Million	132,008 Added 10.27%	1,416,998 $10.1 Million
Q1 2022 May 16, 2022	BUY	$10.03 - $14.09 $6.42 Million - $9.01 Million	639,641 Added 99.12%	1,284,990 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$12.23 - $31.35 $1.79 Million - $4.59 Million	146,309 Added 29.32%	645,349 $9.08 Million
Q3 2021 Nov 15, 2021	BUY	$16.91 - $26.0 $8.44 Million - $13 Million	499,040 New	499,040 $8.78 Million

105

47.2M

353K

1.1K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $510M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.